Table 1 Patient and disease characteristics at baseline (n=64)
Number of patients | 64 |
Male/female (% of patients) | 36 (56%)/28(44%) |
Median age (range) | 68 years (38–82) |
Karnofsky performance status (KPS) | |
0 | 40 (63%) |
1 | 24 (37%) |
Primary disease | |
Colon | 49 (77%) |
Rectal | 15 (23%) |
Number of metastatic sites | |
1 | 38 (59%) |
2 | 21 (33%) |
>2 | 5 (8%) |
Sites of metastasis | |
Liver | 30 (47%) |
Lung | 6 (9%) |
Liver+lung | 13 (20%) |
Lymph nodes | 1 (2%) |
Peritoneum | 1 (2%) |
Others | 13 (20%) |
Prior adjuvant chemotherapy (5-FU based regimen) | |
Yes/no | 17(27%)/47(73%) |
